Cheng L, Albers P, Berney DM, Feldman DR, Daugaard G, Gilligan T, Looijenga LHJ (2018) Testicular cancer. Nat Rev Dis Primers 4(1):29. https://doi.org/10.1038/s41572-018-0029-0. (PMID: 30291251)

Article  PubMed  Google Scholar 

Batool A, Karimi N, Wu XN, Chen SR, Liu YX (2019) Testicular germ cell tumor: a comprehensive review. Cell Mol Life Sci 76(9):1713–1727. https://doi.org/10.1007/s00018-019-03022-7. (Epub 2019 Jan 22 PMID: 30671589)

Article  CAS  PubMed  Google Scholar 

di Pietro A, Vries EG, Gietema JA, Spierings DC, de Jong S (2005) Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. Int J Biochem Cell Biol 37(12):2437–2456. https://doi.org/10.1016/j.biocel.2005.06.014. (Epub 2005 Aug 11 PMID: 16099193)

Article  CAS  PubMed  Google Scholar 

Looijenga LH, Gillis AJ, Stoop H, Biermann K, Oosterhuis JW (2011) Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int J Androl 34(4 Pt 2):e234–e251. https://doi.org/10.1111/j.1365-2605.2011.01157.x. (Epub 2011 May 12 PMID: 21564133)

Article  CAS  PubMed  Google Scholar 

Surveillance, Epidemiology and End Results Program. SEER Stat Fact Sheets: Testis Cancer. National Cancer Institute. Available at: https://seer.cancer.gov/statfacts/html/testis.html. Accessed: Sep 11, 2023)

Voutsadakis IA (2014) The chemosensitivity of testicular germ cell tumors. Cell Oncol (Dordr) 37(2):79–94. https://doi.org/10.1007/s13402-014-0168-6. (Epub 2014 Apr 2 PMID: 24692098)

Article  CAS  PubMed  Google Scholar 

Országhová Z, Kalavska K, Mego M, Chovanec M (2022) Overcoming Chemotherapy Resistance in Germ Cell Tumors. Biomedicines 10(5):972. https://doi.org/10.3390/biomedicines10050972

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ellison AR, Lofing J, Bitter GA (2004) Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain. Nucleic Acids Res 32(18):5321–5338. https://doi.org/10.1093/nar/gkh855

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A et al (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368(6468):258–261. https://doi.org/10.1038/368258a0. (PMID: 8145827)

Article  CAS  PubMed  Google Scholar 

Friedberg EC, McDaniel LD, Schultz RA (2004) The role of endogenous and exogenous DNA damage and mutagenesis. Curr Opin Genet Dev 14(1):5–10. https://doi.org/10.1016/j.gde.2003.11.001. (PMID: 15108798)

Article  CAS  PubMed  Google Scholar 

Murakumo Y, Roth T, Ishii H, Rasio D, Numata S, Croce CM, Fishel R (2000) A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2. J Biol Chem 275(6):4391–4397. https://doi.org/10.1074/jbc.275.6.4391. (PMID: 10660610)

Article  CAS  PubMed  Google Scholar 

Murakumo Y, Ogura Y, Ishii H, Numata S, Ichihara M, Croce CM, Fishel R, Takahashi M (2001) Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7. J Biol Chem 276(38):35644–35651. https://doi.org/10.1074/jbc.M102051200. (Epub 2001 Aug 2 PMID: 11485998)

Article  CAS  PubMed  Google Scholar 

Prakash S, Johnson RE, Prakash L (2005) Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu Rev Biochem 74:317–353. https://doi.org/10.1146/annurev.biochem.74.082803.133250. (PMID: 15952890)

Article  CAS  PubMed  Google Scholar 

Lee YS, Gregory MT, Yang W (2014) Human Pol ζ purified with accessory subunits is active in translesion DNA synthesis and complements Pol η in cisplatin bypass. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.1324001111

Article  PubMed  PubMed Central  Google Scholar 

Clairmont CS, D’Andrea AD (2021) REV7 directs DNA repair pathway choice. Trends Cell Biol 31(12):965–978. https://doi.org/10.1016/j.tcb.2021.05.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Krijger I, Boersma V, Jacobs JJL (2021) REV7: Jack of many trades. Trends Cell Biol 31(8):686–701

Article  PubMed  PubMed Central  Google Scholar 

Olasz J, Mándoky L, Géczi L, Bodrogi I, Csuka O, Bak M (2005) Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors. Anticancer Res 25(6):4319–4324

CAS  PubMed  Google Scholar 

Lothe RA, Peltomäki P, Tommerup N, Fosså SD, Stenwig AE, Børresen AL, Nesland JM (1995) Molecular genetic changes in human male germ cell tumors. Lab Invest 73(5):606–614 (PMID: 7474934)

CAS  PubMed  Google Scholar 

Peltomäki P, Lothe RA, Aaltonen LA, Pylkkänen L, Nyström-Lahti M, Seruca R, David L, Holm R, Ryberg D, Haugen A et al (1993) Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53(24):5853–5855 (PMID: 8261393)

PubMed  Google Scholar 

Devouassoux-Shisheboran M, Mauduit C, Bouvier R, Berger F, Bouras M, Droz JP, Benahmed M (2001) Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours. Mol Hum Reprod 7(12):1099–1105. https://doi.org/10.1093/molehr/7.12.1099. (PMID: 11719586)

Article  CAS  PubMed  Google Scholar 

Mayer F, Gillis AJ, Dinjens W, Oosterhuis JW, Bokemeyer C, Looijenga LH (2002) Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. Cancer Res 62(10):2758–2760 (PMID: 12019150)

CAS  PubMed  Google Scholar 

Dum D, Steurer S, Simon R, Zimmermann PV, Burandt E, Clauditz TS, Fisch M, Rink M, Dahlem R, Höppner W, Zecha H, Doh O, Matthies C, Wilczak W, Sauter G, Fraune C (2021) Mismatch repair deficiency occurs very rarely in seminomas. Transl Androl Urol 10(3):1048–1055

Article  PubMed  PubMed Central  Google Scholar 

Brait M, Maldonado L, Begum S, Loyo M, Wehle D, Tavora FF, Looijenga LH, Kowalski J, Zhang Z, Rosenbaum E, Halachmi S, Netto GJ, Hoque MO (2012) DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma. Br J Cancer 106(2):414–423

Article  CAS  PubMed  Google Scholar 

Huang D, Matin SF, Lawrentschuk N, Roupret M (2018) Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome. Bladder Cancer 4(3):261–268

Article  PubMed  PubMed Central  Google Scholar 

Niimi K, Murakumo Y, Watanabe N, Kato T, Mii S, Enomoto A, Asai M, Asai N, Yamamoto E, Kajiyama H, Shibata K, Kikkawa F, Takahashi M (2014) Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells. Cancer Sci 105(5):545–552

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu C, Luo J, Lu X, Tang Y, Ma Y, Yun Y, Cao J, Cao J, Huang Z, Zhou X, Zhang S (2019) REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2. Cancer Sci 110(3):962–972

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurfurstova D, Bartkova J, Vrtel R, Mickova A, Burdova A, Majera D, Mistrik M, Kral M, Santer FR, Bouchal J, Bartek J (2016) DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer. Mol Oncol 10(6):879–894

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Li L, Chen M, Yu X, Gu Z, Qiu H, Qin G, Long Q, Fu X, Liu T, Li W, Huang W, Shi D, Kang T, Luo M, Wu X, Deng W (2018) MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation. Mol Oncol 12(3):391–405

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okina S, Yanagisawa N, Yokoyama M, Sakurai Y, Numata Y, Umezawa A, Higashihara M, Murakumo Y (2015) High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab. Int J Hematol 102(6):662–669. https://doi.org/10.1007/s12185-015-1880-3. (Epub 2015 Oct 8 PMID: 26449786)